A Pygeum africanum extract with so-called phyto-estrogenic action markedly reduces the volume of true and large prostatic hypertrophy

1995 ◽  
Vol 49 (7-8) ◽  
pp. 341-343 ◽  
Author(s):  
G Mathé ◽  
M Hallard ◽  
CH Bourut ◽  
E Chenu
Keyword(s):  
Prostatic Hypertrophy ◽  
Estrogenic Action ◽  
Pygeum Africanum

The so-called phyto-estrogenic action of Pygeum africanum extract

1995 ◽  
Vol 49 (7-8) ◽  
pp. 339-340 ◽  
Author(s):  
G Mathé ◽  
S Orbach-Arbouys ◽  
E Bizi ◽  
B Court
Keyword(s):  
Estrogenic Action ◽  
Pygeum Africanum

Randomised controlled study with cyproterone acetate (100 mg/die) versus Pygeum africanum (200 mg/die) in benign prostatic hypertrophy

1994 ◽  
Vol 61 (2) ◽  
pp. 127-136
Author(s):  
M. Pavone-Macaluso ◽  
E. Alcini ◽  
A. Bono ◽  
C. Consoli ◽  
U. Jacobellis ◽  
...  
Keyword(s):  
Low Dose ◽  
Prostate Volume ◽  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy ◽  
Controlled Study ◽  
Randomised Controlled Study ◽  
Significant Difference ◽  
Randomised Controlled ◽  
Almost All ◽  
Pygeum Africanum

A multi-centre comparative study was carried out on 143 patients with benign prostatic hypertrophy and reduced or no sexual activity. 74 patients were treated with a low dose of CPA (100 mg a day) and 69 with PYG (200 mg a day), administered orally and assigned randomly. The patients were evaluated at 4,12 and 24 weeks. Results showed a significant statistical difference in favour of the CPA treatment for almost all parameters (flow, post-micturitional residue, symptomatological score). There was a decrease in prostate volume, equal to 19.3% compared to the initial values, only in those patients treated with CPA who completed the treatment. Considerable improvement in nicturia and micturitional urgency was noted in about half the patients, without a significant difference between the two groups.

Laser treatment of benign prostatic hypertrophy

1996 ◽  
Vol 63 (1) ◽  
pp. 77-80
Author(s):  
S. Guazzieri ◽  
W. Cecchetti ◽  
M. Meneguolo ◽  
G. D'incà ◽  
R. Bertoldin
Keyword(s):  
Laser Treatment ◽  
Benign Prostatic Hypertrophy ◽  
Prostatic Hypertrophy ◽  
Laser Source ◽  
Experimental Procedure ◽  
The Usa ◽  
Side Emission ◽  
Pace Maker ◽  
Stable Laser ◽  
Good Flow

— Laser treatment of benign prostatic hypertrophy (BPH) has gradually become more widespread over the last few years. In the USA it is considered an alternative to endoscopic resection as far as insurance payments are concerned. Different methods are used but the most common and suitable one for urologists is the removal and coagulation of the prostatic tissue under visual control (VLAP or ELAP). The Authors report their personal experience in this type of treatment where good results are due to: 1) combination of a powerful, stable laser source 2) durable side-emission contact fibre 3) laser resector, which also in the absence of epicystostomy maintains a good flow during the operation. However, “laser resection” should still be considered an experimental procedure to be used for randomised protocols or on selected patients (high risk of bleeding, Jehovah's witnesses, carriers of pace-maker, etc.).

Effect of Pygeum africanum tadenan on micturition and prostate growth of the rat secondary to coadministered treatment and post-treatment with dihydrotestosterone

Urology ◽  
2003 ◽  
Vol 61 (2) ◽  
pp. 474-478 ◽  
Author(s):  
Yosh Yoshimura ◽  
Osamu Yamaguchi ◽  
Francois Bellamy ◽  
Christos E Constantinou
Keyword(s):  
Post Treatment ◽  
Prostate Growth ◽  
Pygeum Africanum

Cytology in Clinically Benign Cases of Prostatic Hypertrophy

1957 ◽  
Vol 77 (4) ◽  
pp. 648-651 ◽  
Author(s):  
Edna Silva-inzunza ◽  
Waldemar E. Coutts
Keyword(s):  
Prostatic Hypertrophy
Sign in / Sign up

Export Citation Format

Share Document